Skip to main content
Equibles

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in MAIA — MAIA Biotechnology, Inc.

CIK 1632972 PLYMOUTH, MN
Back to MAIA Full portfolio

Position in MAIA

as of Jun 30, 2026 · filed Jul 15, 2026
Position Value
$21,312
+$592 QoQ
Shares Held
14,800
0.0% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 36 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in MAIA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,558,008 across 147 Biotechnology names. MAIA ranks #143 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 45,889 $22,794,442
2 REGN
Regeneron Pharmaceuticals, Inc.
 33,880 $21,125,535
3 INCY
Incyte Corp
 151,505 $17,174,606
4 EXEL
Exelixis, Inc.
 207,728 $11,302,480
5 RPRX
Royalty Pharma plc
 179,888 $10,086,320
6 CORT
Corcept Therapeutics Inc
 76,278 $6,632,372
7 HALO
Halozyme Therapeutics, Inc.
 70,797 $5,541,281
8 AXSM
Axsome Therapeutics, Inc.
 19,919 $4,875,573

All Filings in MAIA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,312 14,800
2026-03-31 $20,720 14,800
2025-12-31 $22,644 14,800
2025-09-30 $22,792 14,800
2025-06-30 $26,640 14,800
2025-03-31 $22,644 14,800
2024-12-31 $29,304 14,800
2024-09-30 $41,588 14,800
2024-06-30 $50,616 14,800
2024-03-31 $35,200 16,000
2023-12-31 $17,316 14,800